Jazz Pharmaceuticals PLC (JAZZ)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	3,809,836	3,720,411	3,685,651	3,662,251	3,569,427	3,471,828	3,371,195	3,194,350	2,999,693	2,864,101	2,628,980	2,436,329	2,361,556	2,277,779	2,214,357	2,184,676	2,158,500	2,053,217	1,985,763	1,953,884
Total assets	US$ in thousands	11,393,400	11,204,100	11,260,500	11,047,100	10,835,300	10,384,700	11,200,100	11,768,900	12,298,600	12,478,200	13,213,000	6,756,470	6,535,900	6,291,960	6,066,500	5,215,300	5,538,900	5,527,850	5,488,660	5,280,240
Total asset turnover		0.33	0.33	0.33	0.33	0.33	0.33	0.30	0.27	0.24	0.23	0.20	0.36	0.36	0.36	0.37	0.42	0.39	0.37	0.36	0.37

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $3,809,836K ÷ $11,393,400K
= 0.33

Based on the data provided, Jazz Pharmaceuticals plc's total asset turnover ratio has fluctuated slightly over the past eight quarters. The ratio has ranged between 0.28 and 0.35, with an average of approximately 0.33. This indicates that, on average, the company generates $0.33 in sales revenue for every dollar of total assets it holds.

A total asset turnover ratio of 0.33 signifies that Jazz Pharmaceuticals is utilizing its assets efficiently to generate revenue. A higher ratio would indicate that the company is more effective in generating sales from its assets. It is important to track this metric over time to assess how effectively the company is utilizing its assets to drive revenue.